Literature DB >> 272137

Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration.

D J Cohen, B A Shaywitz, B Caparulo, J G Young, M B Bowers.   

Abstract

Central nervous system metabolism in six children and one adult with the syndrome of chronic multiple tics was studied by measuring the accumulation of acid metabolites of dopamine and serotonin (homovanillic acid [HVA] and 5-hydroxyindole-acetic acid [5-HIAA], respectively) in the CSF following probenecid administration. The accumulation of 5-HIAA was reduced in patients with multiple tics in contrast with other pediatric patients (N = 27). The degree of reduction in 5-HIAA relative to HVA appeared to be associated with the severity of the tic disorder. With dextroamphetamine, tic symptoms worsened, CSF HVA level decreased, and CSF 5-HIAA concentration increased. These findings suggest an association in Gilles de la Tourette's disease of reduced functioning of inhibitory serotonergic mechanisms and functional dopaminergic overactivity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 272137     DOI: 10.1001/archpsyc.1978.01770260123015

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  11 in total

1.  A controlled study of Tourette syndrome-Revisited: A reply to the letter of Pauls et al.

Authors:  D E Comings; B G Comings
Journal:  Am J Hum Genet       Date:  1988-08       Impact factor: 11.025

Review 2.  The biochemistry of Tourette's syndrome.

Authors:  P R Chokka; G B Baker; R A Bornstein; C M de Groot
Journal:  Metab Brain Dis       Date:  1995-06       Impact factor: 3.584

Review 3.  Gilles de la Tourette syndrome: a review.

Authors:  M Lawden
Journal:  J R Soc Med       Date:  1986-05       Impact factor: 5.344

4.  Tourette's syndrome in a black woman with associated triple X and 9p mosaicism.

Authors:  D N Singh; G L Howe; H W Jordan; S Hara
Journal:  J Natl Med Assoc       Date:  1982-07       Impact factor: 1.798

5.  A clinical study of Gilles de la Tourette syndrome in the United Kingdom.

Authors:  A J Lees; M Robertson; M R Trimble; N M Murray
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-01       Impact factor: 10.154

Review 6.  A controlled study of Tourette syndrome. VII. Summary: a common genetic disorder causing disinhibition of the limbic system.

Authors:  D E Comings
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

7.  Case report: Exacerbation and provocation of tics by imipramine and sulpiride.

Authors:  Christian Eggers; Renate Schepker; Robert Oades
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-07       Impact factor: 4.785

Review 8.  Clinical neurochemistry of autism and associated disorders.

Authors:  J G Young; M E Kavanagh; G M Anderson; B A Shaywitz; D J Cohen
Journal:  J Autism Dev Disord       Date:  1982-06

9.  Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder.

Authors:  Pablo R Moya; Jens R Wendland; Liza M Rubenstein; Kiara R Timpano; Gary A Heiman; Jay A Tischfield; Robert A King; Anne M Andrews; Samanda Ramamoorthy; Francis J McMahon; Dennis L Murphy
Journal:  Mov Disord       Date:  2013-04-29       Impact factor: 10.338

10.  Hispidulin alleviated methamphetamine-induced hyperlocomotion by acting at α6 subunit-containing GABAA receptors in the cerebellum.

Authors:  Yu-Hsiang Liao; Hsin-Jung Lee; Wei-Jan Huang; Pi-Chuan Fan; Lih-Chu Chiou
Journal:  Psychopharmacology (Berl)       Date:  2016-07-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.